KMDJean-Pierre Mainguy, Grant MacDonnell, Stefan Bund...Adis International Limited (now part of Wolters Kluwer Health)2004DOI 10.2165/00822942-200403040-00008
KMD 3213Adis International Limited (now part of Wolters Kluwer Health)Adis International Limited (now part of Wolters Kluwer Health)2004DOI 10.2165/00126839-200405010-00011
Toxicity Profile of Silodosin (KMD-3213)MUTO, Shin-ichiJapan Science and Technology Information Aggregator, Electronic2006DOI 10.1248/yakushi.126.247
Pharmacokinetics and Disposition of Silodosin (KMD-3213)MATSUBARA, YasuhitoJapan Science and Technology Information Aggregator, Electronic2006DOI 10.1248/yakushi.126.237
Tissue selectivity of in vivo α1-adrenoceptor (R) binding in rats by KMD-3213 (KMD), a novel α1-R antagonistTakashi OhkuraThe Japanese Journal of Pharmacology1997DOI 10.1016/s0021-5198(19)44734-3
In vitro and in vivo characterization of [3H] KMD-3213 (KMD) binding to α1-adrenoceptors (R) in rat tissuesYamada, ShizuoJapanese Pharmacological Society1999DOI 10.1016/s0021-5198(19)34533-0
KMD: A Country-specific Genetic Variation Resource for KoreaTimothy David Smith,Human Mutation2012DOI 10.1002/humu.22573
9 Entstehungsgeschichte und bisherige Anwendungen des KMD-Konzepts sowie WeiterentwicklungsmöglichkeitenDe Gruyter OldenbourgDe Gruyter Oldenbourg2020DOI 10.1515/9783110714081-009
α_1-Adrenoceptor Subtype Selectivity and Organ Specificity of Silodosin (KMD-3213)TATEMICHI, SatoshiJapan Science and Technology Information Aggregator, Electronic2006DOI 10.1248/yakushi.kj00004483555
KMD: Korean Mutation Database for Genes Related to DiseasesMi-Hyun ParkHindawi Limited2012DOI 10.1002/humu.22039
Purification and Properties of Leucine Dehydrogenase of Bacillus Natto KMD 1126.MATSUI, KATSUHIKOJapan Science and Technology Information Aggregator, Electronic1977DOI 10.1248/cpb.25.761